News Release 2-Oct-2024 Synthetic THC (dronabinol) was well tolerated by patients without adverse effects often seen from current Alzheimer’s agitation medications Reports and ProceedingsJohns Hopkins Medicine In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that a pill form of the drug dronabinol, an...
Tag: <span>Alzheimer’s disease</span>
Post
Data from largest clinical trial of pre-symptomatic Alzheimer’s disease now widely available
NEWS RELEASE 23-JUL-2024 Researchers from the Keck School of Medicine of USC, who conducted the first and largest phase 3 clinical trial of pre-symptomatic Alzheimer’s disease, have launched a new platform to share de-identified study data with scientists around the world. Business AnnouncementKECK SCHOOL OF MEDICINE OF USC Data from the Anti-Amyloid Treatment in Asymptomatic...
Post
New human cell-based 3D model reveals insights into how immune cells contribute to Alzheimer’s disease
MASSACHUSETTS GENERAL HOSPITAL Key Takeaways – Researchers developed a new 3D model of Alzheimer’s Disease that allows them to study the role of immune cells in the disease– They found that infiltration of immune cells significantly increases in brains with AD pathology and contributes to neurodegeneration and neuroinflammation– The team also identified potential strategies to...